Co-ordinated expression of innate immune molecules during mouse neurulation

Molecular Immunology

Volumn 68, Issue 2, 2015, Pages 253-260

  Jeanes, Angela ^a   Coulthard, Liam G ^a   Mantovani, Susanna ^a,b   Markham, Kathryn ^a   Woodruff, Trent M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Wesley Research Institute   (Australia)

Author keywords

Complement; Immunology; Neurulation; Toll like receptors

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANTIBODY; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C9; COMPLEMENT FACTOR H; COMPLEMENT MEMBRANE ATTACK COMPLEX; DECAY ACCELERATING FACTOR; FORMYLPEPTIDE RECEPTOR; MANNOSE BINDING LECTIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; SECONDARY LYMPHOID TISSUE CHEMOKINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; AGER PROTEIN, MOUSE; COMPLEMENT; ISOPROTEIN; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MYD88 PROTEIN, MOUSE; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENETIC ANALYSIS; INNATE IMMUNITY; MOUSE; MYELOID PROGENITOR CELL; NEURAL TUBE; NEURULATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL EMBRYO; C57BL MOUSE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT LECTIN PATHWAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IN SITU HYBRIDIZATION;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; COMPLEMENT SYSTEM PROTEINS; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNITY, INNATE; IN SITU HYBRIDIZATION; MAP KINASE KINASE KINASES; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; NEURULATION; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 4; TOLL-LIKE RECEPTORS;

EID: 84955728519     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.09.004     Document Type: Article

References (38)

1. Arumugam T.V., Okun E., Tang S.-C., Thundyil J., Taylor S.M., WoodruffT.M. Toll-like receptors in ischemia-reperfusion injury. Shock 2009, 32:4-16. 10.1097/SHK.0b013e318193e333.
2. Bénard M., Gonzalez B.J., Schouft M.-T., Falluel-Morel A., Vaudry D., Chan P., Vaudry H., Fontaine M. Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation. Neuroprotective effect of C5a against apoptotic cell death. J. Biol. Chem. 2004, 279:43487-43496. 10.1074/jbc. M404124200.
3. Bort R., Signore M., Tremblay K., Martinez Barbera J.P., Zaret K.S. Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development. Dev. Biol. 2006, 290:44-56. 10.1016/j.ydbio.2005.11.006.
4. Caballero-Campo P., Domínguez F., Coloma J., Meseguer M., Remohí J., Pellicer A., Simón C. Hormonal and embryonic regulation of chemokines IL-, MCP-1 and RANTES in the human endometrium during the window of implantation. Mol. Hum. 2002, 8. 10.1093/molehr/8.4.375.
5. Carmona-Fontaine C., Theveneau E., Tzekou A., Tada M., Woods M., Page K.M., Parsons M., Lambris J.D., Mayor R. Complement fragment C3a controls mutual attraction during collective migration. Dev. Cell 2011, 10.1016/j.devcel.2011.10.012.
6. Chie K., Katsuo N., Yoshiyuki T., Den-Ichi M., Gen-Ichiro S. Constitutive expression of tnf-α and -β genes in mouse embryo: roles of cytokines as regulator and effector on development. Int. J. Biochem. 1994, 26:111-119. 10.1016/0020-711x(94)90203-8.
7. Christiansen J.H., Dennis C.L., Wicking C.A., Monkley S.J., Wilkinson D.G., Wainwright B.J. Murine Wnt-11 and Wnt-12 have temporally and spatially restricted expression patterns during embryonic development. Mech. Dev. 1995, 51:341-350.
8. Coulthard L.G., WoodruffT.M. Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth. J. Immunol. 2015, 194:3542-3548. 10.4049/jimmunol.1403068.
9. Denny K.J., Coulthard L.G., Jeanes A., Lisgo S., Simmons D.G., Callaway L.K., Wlodarczyk B., Finnell R.H., WoodruffT.M., Taylor S.M. C5a receptor signaling prevents folate deficiency-induced neural tube defects in mice. J. Immunol. 2013, 190:3493-3499. 10.4049/jimmunol.1203072.
10. Denny K.J., Jeanes A., Fathe K., Finnell R.H., Taylor S.M., WoodruffT.M. Neural tube defects, folate, and immune modulation. Birth Defects Res. Part A Clin. Mol. Teratol. 2013, 97:602-609. 10.1002/bdra.23177.
11. Fang P., Schachner M., Shen Y.-Q. HMGB1 in development and diseases of the central nervous system. Mol. Neurobiol. 2012, 45:499-506. 10.1007/s12035-012-8264-y.
12. Germain L., Boluin M.-J., Marceau N. Biliary epithelial and hepatocytic cell lineage relationships in embryonic rat liver as determined by the differential expression of cytokeratins, α-Fetoprotein, albumin, and cell surface-exposed components. Cancer Res. 1988, 48:4909-4918.
13. Hashimoto C., Hudson K.L., Anderson K.V. The Toll gene of drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 1988, 52:269-279. 10.1016/0092-8674(88)90516-8.
14. Haucke E., Navarrete Santos A., Simm A., Henning C., Glomb M.A., Gürke J., Schindler M., Fischer B., Navarrete Santos A. Accumulation of advanced glycation end products in the rabbit blastocyst under maternal diabetes. Reproduction 2014, 148:169-178. 10.1530/rep-14-0149.
15. Hawksworth O.A., Coulthard L.G., Taylor S.M., Wolvetang E.J., WoodruffT.M. Brief report: complement C5a promotes human embryonic stem cell pluripotency in the absence of FGF2. Stem Cells 2014, 32:3278-3284. 10.1002/stem.1801.
16. Haynes T., Luz-Madrigal A., Reis E.S., Ruiz N.P.E., Grajales-Esquivel E., Tzekou A., Tsonis P.A., Lambris J.D., Del Rio-Tsonis K. Complement anaphylatoxin C3a is a potent inducer of embryonic chick retina regeneration. Nat. Commun. 2013, 4. 10.1038/ncomms3312.
17. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 1995, 270:25752-25761.
18. Kaul D., Habbel P., Derkow K., Krüger C., Franzoni E., Wulczyn F.G., Bereswill S., Nitsch R., Schott E., Veh R., Naumann T., Lehnardt S. Expression of Toll-like receptors in the developing brain. PLoS One 2012, 7:e37767. 10.1371/journal.pone.0037767.
19. Kimura Y., Madhavan M., Call M.K., Santiago W., Tsonis P.A., Lambris J.D., Del Rio-Tsonis K. Expression of complement 3 and complement 5 in newt limb and lens regeneration. J. Immunol. 2003, 170:2331-2339.
20. Klos A., Tenner A.J., Johswich K.-O., Ager R.R., Reis E.S., Köhl J. The role of the anaphylatoxins in health and disease. Mol. Immunol. 2009, 46:2753-2766. 10.1016/j.molimm.2009.04.027.
21. Klos A., Wende E., Wareham K.J., Monk P.N. International union of pharmacology. LXXXVII. Complement peptide C5a, C4a, and C3a receptors. Pharmacol. Rev. 2013, 65:500-543. 10.1124/pr.111.005223.
22. Konishi H., Nakatsuka M., Chekir C., Noguchi S., Kamada Y., Sasaki A., Hiramatsu Y. Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts. Hum. Reprod. 2004, 19:2156-2162. 10.1093/humrep/deh389.
23. Kung J.W., Currie I.S., Forbes S.J., Ross J.A. Liver development, regeneration, and carcinogenesis. J. Biomed. Biotechnol. 2010, 2010:984248.
24. Lathia J.D., Okun E., Tang S.-C., Griffioen K., Cheng A., Mughal M.R., Laryea G., Selvaraj P.K., ffrench-Constant C., Magnus T., Arumugam T.V., Mattson M.P. Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation. J. Neurosci. 2008, 28:13978-13984. 10.1523/JNEUROSCI.2140-08.2008.
25. Le Y., Murphy P.M., Wang J.M. Formyl-peptide receptors revisited. Trends Immunol. 2002, 23:541-548. 10.1016/s1471-4906(02)02316-5.
26. Lee S.Y., Lee M.-S., Lee H.-Y., Kim S.D., Shim J.W., Jo S.H., Lee J.W., Kim J.Y., Choi Y.-W., Baek S.-H., Ryu S.H., Bae Y.-S. F2L, a peptide derived from heme-binding protein, inhibits LL-37-induced cell proliferation and tube formation in human umbilical vein endothelial cells. FEBS Lett. 2008, 582:273-278. 10.1016/j.febslet.2007.12.015.
27. Lu Z.-Y., Morales M., Khartulyari S., Mei M., Murphy K.M., Stanislawska-Sachadyn A., Summers C.M., Huang Y., Von Feldt, Blair J.M., Mitchell I.A., Whitehead L.E. Genetic and biochemical determinants of serum concentrations of monocyte chemoattractant protein-1, a potential neural tube defect risk factor. Birth Defects Res. Part A Clin. Mol. Teratol. 2008, 82:736-741. 10.1002/bdra.20507.
28. Manthey H.D., WoodruffT.M., Taylor S.M., Monk P.N. Complement component 5a (C5a). Int. J. Biochem. Cell Biol. 2009, 41:2114-2117. 10.1016/j.biocel.2009.04.005.
29. McLin V.A., Hu C.-H., Shah R., Jamrich M. Expression of complement components coincides with early patterning and organogenesis in Xenopus laevis. Int. J. Dev. Biol. 2008, 52:1123-1133. 10.1387/ijdb.072465v.
30. Okun E., Griffioen K.J., Son T.G., Lee J.-H., Roberts N.J., Mughal M.R., Hutchison E., Cheng A., Arumugam T.V., Lathia J.D., van Praag H., Mattson M.P. TLR2 activation inhibits embryonic neural progenitor cell proliferation. J. Neurochem. 2010, 114:462-474. 10.1111/j.1471-4159.2010.06778.x.
31. Palis J., Robertson S., Kennedy M., Wall C., Keller G. Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development 1999, 126:5073-5084.
32. Pasparakis M., Alexopoulou L., Episkopou V., Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 1996, 184:1397-1411. 10.1084/jem.184.4.1397.
33. Rahpeymai Y., Hietala M.A., Wilhelmsson U., Fotheringham A., Davies I., Nilsson A.-K., Zwirner J., Wetsel R.A., Gerard C., Pekny M., Pekna M. Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J. 2006, 25:1364-1374. 10.1038/sj.emboj.7601004.
34. Rooryck C., Diaz-Font A., Osborn D.P.S., Chabchoub E., Hernandez-Hernandez V., Shamseldin H., Kenny J., Waters A., Jenkins D., Kaissi A.A., Leal G.F., Dallapiccola B., Carnevale F., Bitner-Glindzicz M., Lees M., Hennekam R., Stanier P., Burns A.J., Peeters H., Alkuraya F.S., Beales P.L. Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome. Nat. Genet. 2011, 43:197-203. 10.1038/ng.757.
35. Selander B., Mårtensson U., Weintraub A., Holmström E., Matsushita M., Thiel S., Jensenius J.C., Truedsson L., Sjöholm A.G. Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J. Clin. Invest. 2006, 116:1425-1434. 10.1172/JCI25982.
36. Simmons D.G., Fortier A.L., Cross J.C. Diverse subtypes and developmental origins of trophoblast giant cells in the mouse placenta. Dev. Biol. 2007, 304:567-578. 10.1016/j.ydbio.2007.01.009.
37. WoodruffT.M., Lee J.D., Noakes P.G. Role for terminal complement activation in amyotrophic lateral sclerosis disease progression. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E3-E4. 10.1073/pnas.1321248111.
38. WoodruffT.M., Nandakumar K.S., Tedesco F. Inhibiting the C5-C5a receptor axis. Mol. Immunol. 2011, 48:1631-1642. 10.1016/j.molimm.2011.04.014.